Literature DB >> 9646799

Benign and malignant ovarian masses: selection of the most discriminating gray-scale and Doppler sonographic features.

D L Brown1, P M Doubilet, F H Miller, M C Frates, F C Laing, D N DiSalvo, C B Benson, M H Lerner.   

Abstract

PURPOSE: To determine the gray-scale and Doppler sonographic features that best enable discrimination between malignant and benign ovarian masses and develop a scoring system for accurate diagnosis with these features.
MATERIALS AND METHODS: Gray-scale and Doppler sonographic features of 211 adnexal masses were correlated with the final diagnosis; the most discriminating features for malignancy were selected with stepwise logistic regression.
RESULTS: Twenty-eight masses were malignant and 183 benign. All masses with a markedly hyperechoic solid component or no solid component were benign. For masses with a nonhyperechoic solid component, additional features that allowed statistically significant discrimination of benignity from malignancy were, in decreasing order of importance, (a) location of flow at conventional color Doppler imaging, (b) amount of free intraperitoneal fluid, and (c) presence and thickness of septations. A scoring formula that made use of values based on the logistic regression equation had an area under the receiver operating characteristic curve of 0.98 +/- 0.01. The cutoff score with the highest accuracy had a sensitivity of 93% and specificity of 93%.
CONCLUSION: A solid component is the most statistically significant predictor of a malignant ovarian mass. A multiparameter scoring system that uses three gray-scale and one Doppler feature, developed by means of stepwise logistic regression, has high sensitivity and specificity for predicting malignancy.

Entities:  

Mesh:

Year:  1998        PMID: 9646799     DOI: 10.1148/radiology.208.1.9646799

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  14 in total

Review 1.  Management of asymptomatic ovarian and other adnexal cysts imaged at US: Society of Radiologists in Ultrasound Consensus Conference Statement.

Authors:  Deborah Levine; Douglas L Brown; Rochelle F Andreotti; Beryl Benacerraf; Carol B Benson; Wendy R Brewster; Beverly Coleman; Paul Depriest; Peter M Doubilet; Steven R Goldstein; Ulrike M Hamper; Jonathan L Hecht; Mindy Horrow; Hye-Chun Hur; Mary Marnach; Maitray D Patel; Lawrence D Platt; Elizabeth Puscheck; Rebecca Smith-Bindman
Journal:  Radiology       Date:  2010-05-26       Impact factor: 11.105

2.  Screening for ovarian cancer: imaging challenges and opportunities for improvement.

Authors:  K B Mathieu; D G Bedi; S L Thrower; A Qayyum; R C Bast
Journal:  Ultrasound Obstet Gynecol       Date:  2018-03       Impact factor: 7.299

3.  MR imaging compared with intraoperative frozen-section examination for the diagnosis of adnexal tumors; correlation with final histology.

Authors:  Marc Bazot; Jinane Nassar-Slaba; Isabelle Thomassin-Naggara; Annie Cortez; Serge Uzan; Emile Daraï
Journal:  Eur Radiol       Date:  2006-03-18       Impact factor: 5.315

Review 4.  Pelvic incidentalomas.

Authors:  R M Gore; G M Newmark; K H Thakrar; U K Mehta; J W Berlin
Journal:  Cancer Imaging       Date:  2010-10-04       Impact factor: 3.909

5.  Multimodality imaging of ovarian cystic lesions: Review with an imaging based algorithmic approach.

Authors:  Ashish P Wasnik; Christine O Menias; Joel F Platt; Usha R Lalchandani; Deepak G Bedi; Khaled M Elsayes
Journal:  World J Radiol       Date:  2013-03-28

6.  Surgical intervention for adnexal masses during pregnancy.

Authors:  E Telli; O T Yalcin; S S Ozalp; H Hassa
Journal:  BMJ Case Rep       Date:  2013-06-28

7.  Angiogenesis and vascular survival ability in ovarian adenocarcinomas.

Authors:  A Giatromanolaki; E Sivridis; P Tsikouras; I Manavis; G Maroulis; M I Koukourakis
Journal:  Virchows Arch       Date:  2004-09-09       Impact factor: 4.064

Review 8.  Cross talk between ceramide and redox signaling: implications for endothelial dysfunction and renal disease.

Authors:  Pin-Lan Li; Yang Zhang
Journal:  Handb Exp Pharmacol       Date:  2013

9.  EANM guideline on the role of 2-[18F]FDG PET/CT in diagnosis, staging, prognostic value, therapy assessment and restaging of ovarian cancer, endorsed by the American College of Nuclear Medicine (ACNM), the Society of Nuclear Medicine and Molecular Imaging (SNMMI) and the International Atomic Energy Agency (IAEA).

Authors:  Roberto C Delgado Bolton; Nicolas Aide; Patrick M Colletti; Annamaria Ferrero; Diana Paez; Andrea Skanjeti; Francesco Giammarile
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-07-03       Impact factor: 9.236

10.  Breast angiosarcoma metastatic to the ovary.

Authors:  Frederico F Souza; Amol Katkar; Annick D Van den Abbeele; Pamela J Dipiro
Journal:  Case Rep Med       Date:  2009-06-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.